Previous 10 | Next 10 |
LA JOLLA, Calif., June 23, 2020 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that it has received a Notice of Inte...
Quick Take Pliant Therapeutics ( PLRX ) intends to raise $90 million from the sale of its common stock in an IPO, plus another $10 million in a concurrent private placement, according to an amended registration statement . The company is developing treatments for fibrosis, cancer and othe...
The outbreak of the novel coronavirus disease COVID-19 rapidly spreads around the globe. The various biotechnology firms, scientists, and physicians have been racing to understand this new virus and the pathophysiology of this disease to uncover possible treatment regimens and discover effective...
LA JOLLA, Calif., April 20, 2020 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that it has received a Notice of Allowance from the U.S....
Gainers: NeuroMetrix (NASDAQ: NURO ) +147% . More news on: NeuroMetrix, Inc., Sonnet BioTherapeutics Holdings, Inc., Neovasc Inc., Stocks on the move, , Read more ...
SCWorx (NASDAQ: WORX ) +171% on order for 2M COVID-19 blood tests. More news on: SCWorx Corp., Can-Fite BioPharma Ltd., Independence Contract Drilling, Inc., Stocks on the move, , Read more ...
April 13, 2020 Palm Beach, FL – April 13, 2020 – The search for a vaccine for the global health crisis is being conducted by companies and countries around the world. Some are taking a cue from older antivirals. Some are tapping tried-and-true technologies, and other...
Gainers: Independence Contract Drilling (NYSE: ICD ) +204% . More news on: Independence Contract Drilling, Inc., Pluristem Therapeutics Inc., Nautilus, Inc., Stocks on the move, , Read more ...
Gainers: Moleculin Biotech (NASDAQ: MBRX ) +121% . More news on: Moleculin Biotech, Inc., Ellington Financial Inc., Intelsat S.A., Stocks on the move, , Read more ...
MediciNova (NASDAQ: MNOV ) plans to initiate a clinical trial of MN-166 (ibudilast) for acute respiratory distress syndrome caused by COVID-19. More news on: MediciNova, Inc., Healthcare stocks news, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Company to rededicate efforts toward updating stakeholders on corporate vision, strategy, and ongoing activities LA JOLLA, Calif., June 20, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market o...
LA JOLLA, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that it has received a Notice of Allowance from the U.S....
LA JOLLA, Calif., June 03, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that MediciNova’s collaborator, Gilbert Youssef, M.D....